Recursion Pharmaceuticals (RXRX) Q3 2025 Earnings

Aug 5Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.53
-0.46
-0.4
-0.33

Details

Expected EPS
-0.353333
Actual EPS
-0.41
Surprise EPS
-0.06
Surprise Percent
-16.04%

Description

⁨Recursion Pharmaceuticals⁩ (⁦RXRX⁩) has reported earnings of ⁦-0.41⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts